VYCO Stock Overview
Designs, develops, and markets neurological medical devices and therapies in the United States and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Vycor Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.075 |
| 52 Week High | US$0.13 |
| 52 Week Low | US$0.033 |
| Beta | 0.49 |
| 11 Month Change | -3.21% |
| 3 Month Change | n/a |
| 1 Year Change | 16.15% |
| 33 Year Change | -30.38% |
| 5 Year Change | -46.07% |
| Change since IPO | -99.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| VYCO | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -12.2% | 0.9% | 2.2% |
| 1Y | 16.2% | 21.9% | 32.6% |
Return vs Industry: VYCO underperformed the US Medical Equipment industry which returned 20.8% over the past year.
Return vs Market: VYCO underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| VYCO volatility | |
|---|---|
| VYCO Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: VYCO's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine VYCO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 8 | Peter Zachariou | www.vycormedical.com |
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries.
Vycor Medical, Inc. Fundamentals Summary
| VYCO fundamental statistics | |
|---|---|
| Market cap | US$2.52m |
| Earnings (TTM) | -US$514.60k |
| Revenue (TTM) | US$1.44m |
1.7x
P/S Ratio-4.9x
P/E RatioIs VYCO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VYCO income statement (TTM) | |
|---|---|
| Revenue | US$1.44m |
| Cost of Revenue | US$150.99k |
| Gross Profit | US$1.29m |
| Other Expenses | US$1.81m |
| Earnings | -US$514.60k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.015 |
| Gross Margin | 89.53% |
| Net Profit Margin | -35.68% |
| Debt/Equity Ratio | -26.4% |
How did VYCO perform over the long term?
See historical performance and comparison